| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |